The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TSH Resources Bhd
KLSE:TSH
|
MY |
|
S
|
Synopex Inc
KOSDAQ:025320
|
KR |
|
IOI Corporation Bhd
KLSE:IOICORP
|
MY |
|
T
|
Tune Protect Group Bhd
KLSE:TUNEPRO
|
MY |
|
B
|
BEC World PCL
SET:BEC
|
TH |
|
B
|
Belgravia Hartford Capital Inc
CNSX:BLGV
|
CA |
|
Bank of NT Butterfield & Son Ltd
NYSE:NTB
|
BM |
|
Getty Realty Corp
NYSE:GTY
|
US |
|
C
|
China Construction Bank Corp
XMUN:C6T
|
CN |
|
Metrospaces Inc
OTC:MSPC
|
US |
|
Eldorado Gold Corp
TSX:ELD
|
CA |
|
U
|
USBC Inc
AMEX:USBC
|
US |
|
B
|
BKV Industries Ltd
BSE:519500
|
IN |
|
CI Banco SA Institucion de Banca Multiple FF/00939
OTC:CBAOF
|
MX |
|
Estrella Resources Ltd
ASX:ESR
|
AU |
|
N
|
Nxera Pharma Co Ltd
SWB:JSS
|
JP |
|
A
|
Actinogen Medical Ltd
F:3AC
|
AU |
|
Minco Silver Corp
TSX:MSV
|
CA |
|
ME Therapeutics Holdings Inc
F:Q9T
|
CA |
|
N
|
Neurophet Inc
KOSDAQ:380550
|
KR |
|
Duta Pertiwi Tbk PT
IDX:DUTI
|
ID |
|
Eterna Therapeutics Inc
NASDAQ:ERNA
|
US |
|
P
|
Pegmatite One Lithium and Gold Corp
CNSX:PGA
|
CA |
|
Exail Technologies SA
PAR:EXA
|
FR |
TSH Resources Bhd (TSH)’s 12-month stock price forecast through October 2027 has a consensus target of 1.41 MYR, implying 20% upside. The forecast is based on price targets from 9 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for TSH is 1.41 MYR with a low forecast of 1.29 MYR and a high forecast of 1.94 MYR.
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is 1%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 3 years is -11%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 3 years is -8%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 9%. The projected CAGR for the next 3 years is -4%.
Over the last 13 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 3 years is -5%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more